“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Transaction and post-transaction values based on SEC Form 4 weighted average price ($24.54). 10x Genomics offers single cell and spatial genomics instruments, consumables, and software, including ...
PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
10x Genomics TXG recently announced the acquisition of Proteintech Genomics, a division within Proteintech Group that ...
Genomics Inc. research and ratings by Barron's. View TXG revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to ...
Precision medicine company CareDx and 10x Genomics have partnered to launch ImmuneScape, a multiomics program to improve the understanding of transplant organ rejection and variability in patient ...
Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results